These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 12524400)
1. Missing endomysial and reticulin binding of coeliac antibodies in transglutaminase 2 knockout tissues. Korponay-Szabó IR; Laurila K; Szondy Z; Halttunen T; Szalai Z; Dahlbom I; Rantala I; Kovács JB; Fésüs L; Mäki M Gut; 2003 Feb; 52(2):199-204. PubMed ID: 12524400 [TBL] [Abstract][Full Text] [Related]
2. In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. Korponay-Szabó IR; Halttunen T; Szalai Z; Laurila K; Király R; Kovács JB; Fésüs L; Mäki M Gut; 2004 May; 53(5):641-8. PubMed ID: 15082580 [TBL] [Abstract][Full Text] [Related]
4. Tissue transglutaminase antibodies in celiac disease, comparison of an enzyme linked immunosorbent assay and a dot blot assay. Mankaï A; Sakly W; Landolsi H; Gueddah L; Sriha B; Ayadi A; Sfar MT; Skandrani K; Harbi A; Essoussi AS; Korbi S; Fabien N; Jeddi M; Ghedira I Pathol Biol (Paris); 2005 May; 53(4):204-9. PubMed ID: 15850953 [TBL] [Abstract][Full Text] [Related]
5. Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency. Korponay-Szabó IR; Dahlbom I; Laurila K; Koskinen S; Woolley N; Partanen J; Kovács JB; Mäki M; Hansson T Gut; 2003 Nov; 52(11):1567-71. PubMed ID: 14570724 [TBL] [Abstract][Full Text] [Related]
6. Mutagenesis of the catalytic triad of tissue transglutaminase abrogates coeliac disease serum IgA autoantibody binding. Byrne G; Ryan F; Jackson J; Feighery C; Kelly J Gut; 2007 Mar; 56(3):336-41. PubMed ID: 16935926 [TBL] [Abstract][Full Text] [Related]
7. [Relevance of anti-tissue transglutaminase antibodies in coeliac disease diagnosis]. Lepers S; Soula F; Fily S; Fontaine E; Vuye S; Colombel JF; Guimber D; Prin L; Dubucquoi S Ann Biol Clin (Paris); 2003; 61(3):337-43. PubMed ID: 12805013 [TBL] [Abstract][Full Text] [Related]
8. Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis. Dieterich W; Laag E; Bruckner-Tuderman L; Reunala T; Kárpáti S; Zágoni T; Riecken EO; Schuppan D J Invest Dermatol; 1999 Jul; 113(1):133-6. PubMed ID: 10417632 [TBL] [Abstract][Full Text] [Related]
9. Isolation of antigens recognized by coeliac disease autoantibodies and their use in enzyme immunoassay of endomysium and reticulin antibody-positive human sera. Börner H; Osman AA; Meergans T; Weiske T; Mothes T Clin Exp Immunol; 1996 Nov; 106(2):344-50. PubMed ID: 8918583 [TBL] [Abstract][Full Text] [Related]
10. Ultrastructural binding sites of endomysium antibodies from sera of patients with dermatitis herpetiformis and coeliac disease. Kárpáti S; Meurer M; Stolz W; Bürgin-Wolff A; Braun-Falco O; Krieg T Gut; 1992 Feb; 33(2):191-3. PubMed ID: 1541414 [TBL] [Abstract][Full Text] [Related]
11. Comparison of IgA-class reticulin and endomysium antibodies in coeliac disease and dermatitis herpetiformis. Hällström O Gut; 1989 Sep; 30(9):1225-32. PubMed ID: 2806989 [TBL] [Abstract][Full Text] [Related]
12. Prospective antibody case finding of coeliac disease in type-1 diabetes children: need of biopsy revisited. Popp A; Mihu M; Munteanu M; Ene A; Dutescu M; Colcer F; Raducanu D; Laurila K; Anca I; Mäki M Acta Paediatr; 2013 Mar; 102(3):e102-6. PubMed ID: 23211000 [TBL] [Abstract][Full Text] [Related]
13. Intestinal TG3- and TG2-Specific Plasma Cell Responses in Dermatitis Herpetiformis Patients Undergoing a Gluten Challenge. Sankari H; Hietikko M; Kurppa K; Kaukinen K; Mansikka E; Huhtala H; Laurila K; Reunala T; Hervonen K; Salmi T; Lindfors K Nutrients; 2020 Feb; 12(2):. PubMed ID: 32069794 [TBL] [Abstract][Full Text] [Related]
14. Dermatitis herpetiformis: a cutaneous manifestation of coeliac disease. Collin P; Salmi TT; Hervonen K; Kaukinen K; Reunala T Ann Med; 2017 Feb; 49(1):23-31. PubMed ID: 27499257 [TBL] [Abstract][Full Text] [Related]
15. Specific celiac disease antibodies in children on a gluten-free diet. Hogen Esch CE; Wolters VM; Gerritsen SA; Putter H; von Blomberg BM; van Hoogstraten IM; Houwen RH; van der Lely N; Mearin ML Pediatrics; 2011 Sep; 128(3):547-52. PubMed ID: 21859913 [TBL] [Abstract][Full Text] [Related]
16. IgA anti-endomysium antibody. A new immunological marker of dermatitis herpetiformis and coeliac disease. Chorzelski TP; Beutner EH; Sulej J; Tchorzewska H; Jablonska S; Kumar V; Kapuscinska A Br J Dermatol; 1984 Oct; 111(4):395-402. PubMed ID: 6435666 [TBL] [Abstract][Full Text] [Related]
17. Detection of autoantibodies against tissue transglutaminase in patients with celiac disease and dermatitis herpetiformis. Koop I; Ilchmann R; Izzi L; Adragna A; Koop H; Barthelmes H Am J Gastroenterol; 2000 Aug; 95(8):2009-14. PubMed ID: 10950050 [TBL] [Abstract][Full Text] [Related]
18. Intestinal titres of anti-tissue transglutaminase 2 antibodies correlate positively with mucosal damage degree and inversely with gluten-free diet duration in coeliac disease. Tosco A; Auricchio R; Aitoro R; Ponticelli D; Primario M; Miele E; Rotondi Aufiero V; Discepolo V; Greco L; Troncone R; Maglio M Clin Exp Immunol; 2014 Sep; 177(3):611-7. PubMed ID: 24773630 [TBL] [Abstract][Full Text] [Related]